Purchases and Sales Made in Q4 2023 in Nurix Therapeutics, Inc. (NRIX)
This table provides information about the institutional ownership of Nurix Therapeutics, Inc. (NRIX) during Q4 2023. The information is specifically focused on institutions that hold shares of Nurix Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Candriam S.C.A.
|
SELL
|
- |
-50K- 5.16% |
$213K - $536K
|
918K
$20.3M
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-81.6K- 22.45% |
$347K - $874K
|
282K
$6.23M
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
- |
-95.6K- 55.58% |
$406K - $1.02M
|
76.4K
$1.69M
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-117K- 4.3% |
$496K - $1.25M
|
2.6M
$57.4M
|
|
|
Feb 13, 2024
Q4 2023
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-124K- 13.84% |
$528K - $1.33M
|
774K
$17.1M
|
|
|
Feb 14, 2024
Q4 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-129K- 19.51% |
$550K - $1.39M
|
534K
$11.8M
|
|
|
Feb 16, 2024
Q4 2023
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-171K- 87.67% |
$728K - $1.83M
|
24.1K
$533K
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-267K- 41.41% |
$1.13M - $2.86M
|
378K
$8.35M
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-569K- 96.78% |
$2.42M - $6.09M
|
18.9K
$419K
|
|
|
Feb 14, 2024
Q4 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-671K- 82.43% |
$2.85M - $7.19M
|
143K
$3.16M
|
|
|
Feb 14, 2024
Q4 2023
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-815K- 22.86% |
$3.46M - $8.73M
|
2.75M
$60.8M
|
|
|
Feb 14, 2024
Q4 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-853K- 48.07% |
$3.62M - $9.13M
|
921K
$20.4M
|